Method of treating nausea, vomiting, retching or any combination thereof

Details for Australian Patent Application No. 2004204827 (hide)

Owner Dynogen Pharmaceuticals, Inc.

Inventors Landau, Steven B.; Miller, Cheryl L.; Thor, Karl Bruce

Agent Davies Collison Cave

Pub. Number AU-A-2004204827

PCT Pub. Number WO2004/062624

Priority 60/440,076 13.01.03 US; 60/492,478 04.08.03 US

Filing date 13 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 29 June 2006

International Classifications

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

Event Publications

3 February 2005 PCT application entered the National Phase

  PCT publication WO2004/062624 Priority application(s): WO2004/062624

29 June 2006 Application Accepted

  Published as AU-A-2004204827

26 October 2006 Standard Patent Sealed

6 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204831-Improved configuration and process for shift conversion

2004204825-Method of treating functional bowel disorders